Both in Pharmaceuticals
Regeneron Pharmaceuticals vs Vertex Pharmaceuticals
Over the past year REGN returned +44.5% and VRTX returned +31.2%; their daily moves had a correlation of 0.46.
REGN +44.5% VRTX +31.2%Growth of $1, one year, split-adjusted
| Metric | REGN | VRTX |
|---|---|---|
| Price | $927.89 | $558.88 |
| Market cap | $95.99B | $141.65B |
| Today | +13.33% | +3.50% |
| 1 month | +26.3% | +10.3% |
| 6 months | +32.3% | +31.8% |
| Year to date | +20.2% | +23.3% |
| 1 year | +42.1% | +34.0% |
| Revenue growth (YoY) | +36.3% | +12.5% |
| Gross margin | 88.8% | 85.3% |
| Net margin | 38.1% | 33.0% |
| P/E (TTM) | 19.9× | 32.2× |
| Price / sales | 5.7× | 11.3× |
| Net cash | $6.59B | $7.85B |
| Dividend yield | 0.41% | — |
| Volatility (60d) | 37.0% | 28.7% |
| Short % of float | 2.2% | 1.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).